MD20040296A - Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ - Google Patents
Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activInfo
- Publication number
- MD20040296A MD20040296A MDA20040296A MD20040296A MD20040296A MD 20040296 A MD20040296 A MD 20040296A MD A20040296 A MDA20040296 A MD A20040296A MD 20040296 A MD20040296 A MD 20040296A MD 20040296 A MD20040296 A MD 20040296A
- Authority
- MD
- Moldova
- Prior art keywords
- oxcarbazepin
- active ingredient
- prolonged release
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Invenţia se referă la compoziţii farmaceutice, în special la compoziţii pentru administrare orală, care conţin o cantitate eficientă de oxcarbazepină terapeutic eficientă cu eliberare prelungită a ingredientului activ in vitro
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10224177 | 2002-05-31 | ||
DE10224170A DE10224170A1 (de) | 2002-05-31 | 2002-05-31 | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
DE10250566A DE10250566A1 (de) | 2002-05-31 | 2002-10-30 | Pharmazeutische Zusammensetzung, enthaltend Oxcarbazepin mit verzögerter Wirkstofffreisetzung |
PCT/EP2003/005116 WO2003101430A1 (de) | 2002-05-31 | 2003-05-15 | Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
MD20040296A true MD20040296A (ro) | 2005-05-31 |
Family
ID=40600478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20040296A MD20040296A (ro) | 2002-05-31 | 2003-05-15 | Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20050010843A (ro) |
AT (1) | ATE429905T1 (ro) |
DE (1) | DE50311479D1 (ro) |
MD (1) | MD20040296A (ro) |
-
2003
- 2003-05-15 DE DE50311479T patent/DE50311479D1/de not_active Expired - Lifetime
- 2003-05-15 AT AT03730048T patent/ATE429905T1/de not_active IP Right Cessation
- 2003-05-15 KR KR10-2004-7019282A patent/KR20050010843A/ko not_active Application Discontinuation
- 2003-05-15 MD MDA20040296A patent/MD20040296A/ro not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE429905T1 (de) | 2009-05-15 |
DE50311479D1 (de) | 2009-06-10 |
KR20050010843A (ko) | 2005-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076605A1 (en) | Formulations | |
HK1054918A1 (en) | Compounds and compositions for delivering active agents | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
HK1096034A1 (en) | A solid dosage form comprising a fibrate | |
TW200621317A (en) | Pharmaceutical composition | |
UA96449C2 (en) | Stable laquinimod preparations | |
MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
BR0311327A (pt) | Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo | |
SI1121127T1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
PL348419A1 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
AU2002214389A1 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
PL377683A1 (pl) | System terapeutyczny zawierający amoksycylinę i kwas klawulanowy | |
AU2003202550A1 (en) | Pharmaceutical formulations with modified release | |
MD20040296A (ro) | Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ | |
SE0203817D0 (sv) | New composition | |
WO2005062874A3 (en) | Compounds and compositions for delivering active agents | |
WO2001095890A3 (en) | Oral pharmaceutical compositions containing terbinafine | |
MXPA05014012A (es) | Composiciones farmaceuticas que comprenden peranhidro-ciclodextrina. | |
TNSN06299A1 (en) | Oral matrix formulations comprising licarbazepine | |
MY145885A (en) | Controlled release formulations for oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Abandonment or withdrawal of application (patent for invention) |